These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 31523137)

  • 1. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies.
    Barber TM; Hanson P; Weickert MO; Franks S
    Clin Med Insights Reprod Health; 2019; 13():1179558119874042. PubMed ID: 31523137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance.
    Barber TM; Dimitriadis GK; Andreou A; Franks S
    Clin Med (Lond); 2016 Jun; 16(3):262-6. PubMed ID: 27251917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance.
    Barber TM; Dimitriadis GK; Andreou A; Franks S
    Clin Med (Lond); 2015 Dec; 15 Suppl 6():s72-6. PubMed ID: 26634686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and polycystic ovary syndrome.
    Barber TM; Franks S
    Clin Endocrinol (Oxf); 2021 Oct; 95(4):531-541. PubMed ID: 33460482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifestyle and Behavioral Management of Polycystic Ovary Syndrome.
    Brennan L; Teede H; Skouteris H; Linardon J; Hill B; Moran L
    J Womens Health (Larchmt); 2017 Aug; 26(8):836-848. PubMed ID: 28570835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why are women with polycystic ovary syndrome obese?
    Barber TM
    Br Med Bull; 2022 Sep; 143(1):4-15. PubMed ID: 35284917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of changes in dietary habits in polycystic ovary syndrome.
    Pasquali R; Gambineri A
    Reprod Biomed Online; 2004 Apr; 8(4):431-9. PubMed ID: 15149567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.
    Spritzer PM
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):182-7. PubMed ID: 24830595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and polycystic ovary syndrome.
    Barber TM; McCarthy MI; Wass JA; Franks S
    Clin Endocrinol (Oxf); 2006 Aug; 65(2):137-45. PubMed ID: 16886951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
    Elkind-Hirsch KE
    Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L; Teede H
    Hum Reprod Update; 2009; 15(4):477-88. PubMed ID: 19279045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study.
    Romualdi D; Versace V; Tagliaferri V; De Cicco S; Immediata V; Apa R; Guido M; Lanzone A
    J Endocrinol Invest; 2019 Sep; 42(9):1089-1097. PubMed ID: 30847861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of obesity on reproduction in women with polycystic ovary syndrome.
    Pasquali R; Gambineri A; Pagotto U
    BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
    Rosenfield RL; Ehrmann DA
    Endocr Rev; 2016 Oct; 37(5):467-520. PubMed ID: 27459230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity management in women with polycystic ovary syndrome.
    Lim SS; Clifton PM; Noakes M; Norman RJ
    Womens Health (Lond); 2007 Jan; 3(1):73-86. PubMed ID: 19803867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.